Cargando…
Imaging Markers in Genetic Forms of Parkinson’s Disease
Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity, and resting tremor. While the majority of PD cases are sporadic, approximately 15–20% of cases have a genetic component. Advances in neuroimaging techniques have provided...
Autores principales: | Droby, Amgad, Thaler, Avner, Mirelman, Anat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452191/ https://www.ncbi.nlm.nih.gov/pubmed/37626568 http://dx.doi.org/10.3390/brainsci13081212 |
Ejemplares similares
-
Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022) -
Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
por: Droby, Amgad, et al.
Publicado: (2021) -
Brain functional networks reorganization for maintaining gait abilities in aging
por: Droby, Amgad, et al.
Publicado: (2023) -
A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis
por: Giladi, Nir, et al.
Publicado: (2016) -
EEG-Based Mapping of Resting-State Functional Brain Networks in Patients with Parkinson’s Disease
por: Leviashvili, Sarah, et al.
Publicado: (2022)